Generation Bio Co.

NASDAQ: GBIO · Real-Time Price · USD
6.30
-0.36 (-5.41%)
At close: Aug 15, 2025, 3:59 PM
6.33
0.48%
After-hours: Aug 15, 2025, 06:24 PM EDT

Generation Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
765K 8.72M 4.19M 7.55M 4.09M 4.06M 2.88M 2.15M 880K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a 1.31M 1.32M 1.29M 1.31M n/a 1.35M 17.23M 1.22M 1.2M 1.17M 1.17M 1.13M 1.06M
Gross Profit
765K 8.72M 4.19M 7.55M 4.09M 4.06M -18.69M 853K -435K n/a -1.35M -17.23M -1.22M -1.2M -1.17M -1.17M -1.13M -1.06M
Operating Income
-22.92M -16.61M -23.56M -17.88M -23.31M -77.63M -38.42M -31.36M -33.92M -34.87M -34.69M -32.67M -38.48M -35.34M -30.95M -31.66M -30.84M -25.66M
Interest Income
1.99M 1.8M 2.18M 2.57M 2.88M 3.09M 3.23M 3.09M 2.85M 2.77M 2.28M 1.36M 552K 345K 3K n/a 51K 93K
Pretax Income
-20.92M -14.8M -21.38M -15.31M -20.43M -74.54M -35.19M -28.27M -31.07M -32.09M -32.41M -31.31M -37.93M -35M -30.94M -31.86M -30.79M -25.56M
Net Income
-20.92M -14.8M -21.38M -15.31M -20.43M -74.54M -35.19M -28.27M -31.07M -32.09M -30.12M -31.31M -37.38M -34.65M -30.94M -31.86M -30.79M -25.56M
Selling & General & Admin
7.67M 8.83M 8.66M 9.18M 9.52M 10.43M 13.38M 11.64M 12.97M 12.87M 13.08M 11.48M 10.12M 9.79M 9.1M 9.67M 8.19M 6.9M
Research & Development
15.5M 15.36M 15.49M 15.09M 16.39M 14.34M 27.92M 21.86M 21.83M 22M 21.61M 21.19M 28.36M 25.55M 21.85M 21.99M 22.66M 18.75M
Other Expenses
514K 1.14M 3.6M 1.17M 1.5M 56.93M -21.57M -1.29M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
23.68M 25.33M 27.75M 25.44M 27.4M 81.69M 19.73M 32.21M 34.8M 34.87M 34.69M 32.67M 38.48M 35.34M 30.95M 31.66M 30.84M 25.66M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 2.28M n/a 552K 345K n/a 197K n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
23.68M 25.33M 27.75M 25.44M 27.4M 81.69M 41.3M 33.5M 34.8M 34.87M 34.69M 32.67M 38.48M 35.34M 30.95M 31.66M 30.84M 25.66M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.28M n/a -552K -345K n/a n/a n/a n/a
Shares Outstanding (Basic)
6.7M 6.7M 6.67M 6.67M 6.65M 6.64M 6.61M 6.59M 6.57M 6.02M 5.94M 5.89M 5.71M 5.7M 5.67M 5.66M 5.63M 5.54M
Shares Outstanding (Diluted)
6.7M 6.7M 6.67M 6.67M 6.65M 6.64M 6.61M 6.59M 6.57M 6.02M 5.94M 5.89M 5.71M 5.7M 5.69M 5.66M 5.63M 5.54M
EPS (Basic)
-3.12 -2.21 -3.2 -2.29 -3.07 -11.22 -5.33 -4.29 -4.7 -5.3 -5.1 -5.3 -6.5 -6.1 -5.5 -5.6 -5.5 -4.6
EPS (Diluted)
-3.12 -2.21 -3.2 -2.29 -3.07 -11.22 -5.33 -4.29 -4.7 -5.3 -5.1 -5.3 -6.5 -6.1 -5.4 -5.6 -5.5 -4.6
EBITDA
-21.27M -14.33M -18.79M -15.54M -20.55M -19.39M -37.1M -30.06M -32.6M -33.54M -33.34M -31.3M -37.26M -34.15M -29.78M -30.48M -29.71M -24.59M
EBIT
-22.4M -15.47M -19.96M -16.71M -21.81M -20.7M -38.42M -31.36M -33.92M -34.87M -34.69M -32.67M -38.48M -35.34M -30.95M -31.66M -30.84M -25.66M
Depreciation & Amortization
1.13M 1.14M 1.18M 1.18M 1.26M 1.31M 1.32M 1.29M 1.31M 1.33M 1.35M 1.36M 1.22M 1.2M 1.17M 1.17M 1.13M 1.06M